288 related articles for article (PubMed ID: 25939314)
1. Dengue virus requires the CC-chemokine receptor CCR5 for replication and infection development.
Marques RE; Guabiraba R; Del Sarto JL; Rocha RF; Queiroz AL; Cisalpino D; Marques PE; Pacca CC; Fagundes CT; Menezes GB; Nogueira ML; Souza DG; Teixeira MM
Immunology; 2015 Aug; 145(4):583-96. PubMed ID: 25939314
[TBL] [Abstract][Full Text] [Related]
2. Mouse models for dengue vaccines and antivirals.
Plummer EM; Shresta S
J Immunol Methods; 2014 Aug; 410():34-8. PubMed ID: 24440090
[TBL] [Abstract][Full Text] [Related]
3. Monocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for dengue virus replication.
Schmid MA; Harris E
PLoS Pathog; 2014 Dec; 10(12):e1004541. PubMed ID: 25474197
[TBL] [Abstract][Full Text] [Related]
4. Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus Replication.
Suzuki Y; Chin WX; Han Q; Ichiyama K; Lee CH; Eyo ZW; Ebina H; Takahashi H; Takahashi C; Tan BH; Hishiki T; Ohba K; Matsuyama T; Koyanagi Y; Tan YJ; Sawasaki T; Chu JJ; Vasudevan SG; Sano K; Yamamoto N
PLoS Pathog; 2016 Jan; 12(1):e1005357. PubMed ID: 26735137
[TBL] [Abstract][Full Text] [Related]
5. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K
J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106
[TBL] [Abstract][Full Text] [Related]
6. Dengue virus infects macrophages and dendritic cells in a mouse model of infection.
Kyle JL; Beatty PR; Harris E
J Infect Dis; 2007 Jun; 195(12):1808-17. PubMed ID: 17492597
[TBL] [Abstract][Full Text] [Related]
7. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
Soto-Acosta R; Bautista-Carbajal P; Syed GH; Siddiqui A; Del Angel RM
Antiviral Res; 2014 Sep; 109():132-40. PubMed ID: 25017471
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A.
Rattanaburee T; Junking M; Panya A; Sawasdee N; Songprakhon P; Suttitheptumrong A; Limjindaporn T; Haegeman G; Yenchitsomanus PT
Antiviral Res; 2015 Dec; 124():83-92. PubMed ID: 26542647
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
[TBL] [Abstract][Full Text] [Related]
10. Dengue Virus Selectively Annexes Endoplasmic Reticulum-Associated Translation Machinery as a Strategy for Co-opting Host Cell Protein Synthesis.
Reid DW; Campos RK; Child JR; Zheng T; Chan KWK; Bradrick SS; Vasudevan SG; Garcia-Blanco MA; Nicchitta CV
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321322
[TBL] [Abstract][Full Text] [Related]
11. Mast cell-macrophage dynamics in modulation of dengue virus infection in skin.
Chu YT; Wan SW; Anderson R; Lin YS
Immunology; 2015 Sep; 146(1):163-72. PubMed ID: 26059780
[TBL] [Abstract][Full Text] [Related]
12. Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models.
Tang WW; Grewal R; Shresta S
Curr Opin Virol; 2015 Aug; 13():61-6. PubMed ID: 26001278
[TBL] [Abstract][Full Text] [Related]
13. Suppressed expression of miR-378 targeting gzmb in NK cells is required to control dengue virus infection.
Liu S; Chen L; Zeng Y; Si L; Guo X; Zhou J; Fang D; Zeng G; Jiang L
Cell Mol Immunol; 2016 Sep; 13(5):700-8. PubMed ID: 26166761
[TBL] [Abstract][Full Text] [Related]
14. Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model.
Barros VE; dos Santos-Junior NN; Amarilla AA; Soares AM; Lourencini R; Trabuco AC; Aquino VH
BMC Microbiol; 2015 Sep; 15():189. PubMed ID: 26415508
[TBL] [Abstract][Full Text] [Related]
15. Effect of high doses of vitamin D supplementation on dengue virus replication, Toll-like receptor expression, and cytokine profiles on dendritic cells.
Martínez-Moreno J; Hernandez JC; Urcuqui-Inchima S
Mol Cell Biochem; 2020 Jan; 464(1-2):169-180. PubMed ID: 31758375
[TBL] [Abstract][Full Text] [Related]
16. Alpha-mangostin inhibits both dengue virus production and cytokine/chemokine expression.
Tarasuk M; Songprakhon P; Chimma P; Sratongno P; Na-Bangchang K; Yenchitsomanus PT
Virus Res; 2017 Aug; 240():180-189. PubMed ID: 28864423
[TBL] [Abstract][Full Text] [Related]
17. Repurposing of prochlorperazine for use against dengue virus infection.
Simanjuntak Y; Liang JJ; Lee YL; Lin YL
J Infect Dis; 2015 Feb; 211(3):394-404. PubMed ID: 25028694
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 facilitates dengue virus replication and serves as a potential target for developing antiviral agents.
Lin CK; Tseng CK; Wu YH; Liaw CC; Lin CY; Huang CH; Chen YH; Lee JC
Sci Rep; 2017 Mar; 7():44701. PubMed ID: 28317866
[TBL] [Abstract][Full Text] [Related]
19. Dengue Virus Evolution under a Host-Targeted Antiviral.
Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
[TBL] [Abstract][Full Text] [Related]
20. Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection.
Assunção-Miranda I; Amaral FA; Bozza FA; Fagundes CT; Sousa LP; Souza DG; Pacheco P; Barbosa-Lima G; Gomes RN; Bozza PT; Da Poian AT; Teixeira MM; Bozza MT
FASEB J; 2010 Jan; 24(1):218-28. PubMed ID: 19776337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
